Post-COVID-19 vaccine acute encephalitis in an adult patient: A case report and literature review

Several vaccines were approved after COVID-19 pandemic, which have been fast-tracked for emergency use. The short- and long-term safety profile has been an area of concern. We presented a patient with encephalitis followed by hyponatremia who developed hallucination and seizure 1 day after receiving the second dose of Sinopharm vaccine.

Automated summary

This case report highlights a patient who experienced encephalitis, hyponatremia, hallucination, and seizure shortly after receiving the second dose of Sinopharm vaccine, raising concerns about the safety profile of the vaccine.